Equifax introduces Healthcare Report™ Credential ID
New solution designed to help streamline healthcare provider onboarding and better safeguard patient care ATLANTA, Sept. 22, 2026 /PRNewswire/ -- Equifax® (NYSE:EFX) today announced the launch of Healthcare Report™ Credential ID, an automated screening solution designed to help streamline...
Covered in this story
What has happened since
- Equifax is up 17.0% since this was published, 29 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Equifax
- Rothschild & Co Redburn: $193 → $235 by Aug 2027 · Buy via Investing.com
- RBC Capital Markets: $170 → $194 by Jul 2027 · Outperform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $EFX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Equifax →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.